Harbin Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Harbin Pharmaceutical Group has a total shareholder equity of CN¥5.6B and total debt of CN¥2.0B, which brings its debt-to-equity ratio to 35.3%. Its total assets and total liabilities are CN¥14.1B and CN¥8.5B respectively. Harbin Pharmaceutical Group's EBIT is CN¥648.1M making its interest coverage ratio 1088.6. It has cash and short-term investments of CN¥2.8B.
Key information
35.3%
Debt to equity ratio
CN¥1.98b
Debt
| Interest coverage ratio | 1088.6x |
| Cash | CN¥2.85b |
| Equity | CN¥5.61b |
| Total liabilities | CN¥8.53b |
| Total assets | CN¥14.15b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 600664's short term assets (CN¥10.5B) exceed its short term liabilities (CN¥8.1B).
Long Term Liabilities: 600664's short term assets (CN¥10.5B) exceed its long term liabilities (CN¥439.0M).
Debt to Equity History and Analysis
Debt Level: 600664 has more cash than its total debt.
Reducing Debt: 600664's debt to equity ratio has increased from 6.3% to 35.3% over the past 5 years.
Debt Coverage: 600664's debt is well covered by operating cash flow (25.1%).
Interest Coverage: 600664's interest payments on its debt are well covered by EBIT (1088.6x coverage).